Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michel Probst is active.

Publication


Featured researches published by Michel Probst.


Eating Disorders | 1995

The Body Attitude Test for Patients with an Eating Disorder: Psychometric Characteristics of a New Questionnaire

Michel Probst; Walter Vandereycken; Herman Van Coppenolle; Johan Vanderlinden

Abstract The Body Attitude Test (BAT) is a new self-report questionnaire developed for female patients suffering from eating disorders. Its psychometric characteristics have been tested in a large number of patients and control subjects (eating disorders, Weight Watchers, and normal subjects). Repeated analyses yielded a stable four factor structure: negative appreciation of body size, lack of familiarity with ones own body, general body dissatisfaction, and a rest factor. Repeated tests in different subgroups have shown the BAT to be reliable and valid, as well as easy and practical (only 20 items).


World Psychiatry | 2016

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis

Davy Vancampfort; Christoph U. Correll; Britta Galling; Michel Probst; Marc De Hert; Philip B. Ward; Simon Rosenbaum; Fiona Gaughran; John Lally; Brendon Stubbs

Type 2 diabetes mellitus (T2DM) is highly predictive of cardiovascular diseases and can have particularly deleterious health impacts in people with severe mental illness (SMI), i.e. schizophrenia, bipolar disorder or major depressive disorder. This meta‐analysis aimed: a) to describe pooled frequencies of T2DM in people with SMI; b) to analyze the influence of demographic, illness and treatment variables as well as T2DM assessment methods; and c) to describe T2DM prevalence in studies directly comparing persons with each specific SMI diagnosis to general population samples. The trim and fill adjusted pooled T2DM prevalence among 438,245 people with SMI was 11.3% (95% CI: 10.0%‐12.6%). In antipsychotic‐naïve participants, the prevalence of T2DM was 2.9% (95% CI: 1.7%‐4.8%). There were no significant diagnostic subgroup differences. A comparative meta‐analysis established that multi‐episode persons with SMI (N=133,470) were significantly more likely to have T2DM than matched controls (N=5,622,664): relative risk, RR=1.85, 95% CI: 1.45‐2.37, p<0.001. The T2DM prevalence was consistently elevated in each of the three major diagnostic subgroups compared to matched controls. Higher T2DM prevalences were observed in women with SMI compared to men (RR=1.43, 95% CI: 1.20‐1.69, p<0.001). Multi‐episode (versus first‐episode) status was the only significant predictor for T2DM in a multivariable meta‐regression analysis (r2=0.52, p<0.001). The T2DM prevalence was higher in patients prescribed antipsychotics, except for aripriprazole and amisulpride. Routine screening and multidisciplinary management of T2DM is needed. T2DM risks of individual antipsychotic medications should be considered when making treatment choices.


World Psychiatry | 2013

A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls

Davy Vancampfort; M. Wampers; Alex J. Mitchell; Christoph U. Correll; Amber De Herdt; Michel Probst; Marc De Hert

A meta‐analysis was conducted to explore the risk for cardio‐metabolic abnormalities in drug naïve, first‐episode and multi‐episode patients with schizophrenia and age‐ and gender‐ or cohort‐matched general population controls. Our literature search generated 203 relevant studies, of which 136 were included. The final dataset comprised 185,606 unique patients with schizophrenia, and 28 studies provided data for age‐ and gender‐matched or cohort‐matched general population controls (n=3,898,739). We found that multi‐episode patients with schizophrenia were at increased risk for abdominal obesity (OR=4.43; CI=2.52‐7.82; p<0.001), hypertension (OR=1.36; CI=1.21‐1.53; p<0.001), low high‐density lipoprotein cholesterol (OR=2.35; CI=1.78‐3.10; p<0.001), hypertriglyceridemia (OR=2.73; CI=1.95‐3.83; p<0.001), metabolic syndrome (OR=2.35; CI=1.68‐3.29; p<0.001), and diabetes (OR=1.99; CI=1.55‐2.54; p<0.001), compared to controls. Multi‐episode patients with schizophrenia were also at increased risk, compared to first‐episode (p<0.001) and drug‐naïve (p<0.001) patients, for the above abnormalities, with the exception of hypertension and diabetes. Our data provide further evidence supporting WPA recommendations on screening, follow‐up, health education and lifestyle changes in people with schizophrenia.


Disability and Rehabilitation | 2011

State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study.

Davy Vancampfort; Marc De Hert; Jan Knapen; Martien Wampers; Hella Demunter; Seppe Deckx; Katrien Maurissen; Michel Probst

Purpose. Worsening of schizophrenia symptoms is related to stress and anxiety. People with schizophrenia often experience difficulties in coping with stress and possess a limited repertoire of coping strategies. A randomised comparative trial was undertaken in patients with schizophrenia to evaluate changes in state anxiety, psychological stress and subjective well-being after single sessions of yoga and aerobic exercise compared with a control condition. Method. Forty participants performed a single 30-min yoga session, 20-min of aerobic exercise on a bicycle ergometre at self-selected intensity and a 20-min no exercise control condition in random order. Results. After single sessions of yoga and aerobic exercise individuals with schizophrenia or schizoaffective disorder showed significantly decreased state anxiety (p < 0.0001), decreased psychological stress (p < 0.0001) and increased subjective well-being (p < 0.0001) compared to a no exercise control condition. Effect sizes ranged from 0.82 for psychological stress after aerobic exercise to 1.01 for state anxiety after yoga. The magnitude of the changes did not differ significantly between yoga and aerobic exercise. Conclusion. People with schizophrenia and physiotherapists can choose either yoga or aerobic exercise in reducing acute stress and anxiety taking into account the personal preference of each individual.


General Hospital Psychiatry | 2016

Prevalence and predictors of treatment dropout from physical activity interventions in schizophrenia: a meta-analysis.

Davy Vancampfort; Simon Rosenbaum; Felipe B. Schuch; Philip B. Ward; Michel Probst; Brendon Stubbs

OBJECTIVE Physical activity interventions have been shown to improve the health of people with schizophrenia, yet treatment dropout poses an important challenge in this population, and rates vary substantially across studies. We conducted a meta-analysis to investigate the prevalence and predictors of treatment dropout in physical activity interventions in people with schizophrenia. METHOD We systematically searched major electronic databases from inception until August 2015. Randomized controlled trials of physical activity interventions in people with schizophrenia reporting dropout rates were included. Two independent authors conducted searches and extracted data. Random-effects meta-analysis and meta-regression analyses were conducted. RESULTS In 19 studies, 594 patients with schizophrenia assigned to exercise interventions were investigated (age=37.2 years, 67.5% male, range=37.5%-100%). Trim and fill adjusted treatment dropout rate was 26.7% [95% confidence interval (CI)=19.7%-35.0%], which is more than double than in nonactive control interventions (odds ratio=2.15, 95% CI=1.29-3.58, P=.003). In the multivariate regression, qualification of the professional delivering the intervention (β=-1.06, 95% CI=-1.77 to -0.35, P=.003) moderated treatment dropout rates, while continuous supervision of physical activity approached statistical significance (P=.05). CONCLUSIONS Qualified professionals (e.g., physical therapists/exercise physiologists) should prescribe supervised physical activity for people with schizophrenia to enhance adherence, improve psychiatric symptoms and reduce the onset and burden of cardiovascular disease.


Depression and Anxiety | 2015

TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META‐ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS

Davy Vancampfort; Alex J. Mitchell; Marc De Hert; Pascal Sienaert; Michel Probst; Roselien Buys; Brendon Stubbs

Patients with depression may be at increased risk of type 2 diabetes mellitus (T2DM), which is a risk factor for cardiovascular diseases and premature mortality. We aimed to clarify the prevalence and predictors of T2DM in patients with major depressive disorder (MDD) and where possible compare the prevalence of T2DM in those with MDD versus general population controls.


Acta Psychiatrica Scandinavica | 2012

Yoga in schizophrenia: a systematic review of randomised controlled trials

Davy Vancampfort; Kristof Vansteelandt; T. Scheewe; Michel Probst; Jan Knapen; A. De Herdt; M. De Hert

Vancampfort D, Vansteelandt K, Scheewe T, Probst M, Knapen J, De Herdt A, De Hert M. Yoga in schizophrenia: a systematic review of randomised controlled trials.


Disability and Rehabilitation | 2013

Can cognitive behavioural therapy based strategies be integrated into physiotherapy for the prevention of chronic low back pain? A systematic review

Emanuel Brunner; Amber De Herdt; Philippe Minguet; Se Sergio Baldew; Michel Probst

Purpose: The primary purpose was to detect randomized controlled trials investigating cognitive behaviour therapy-based (CBT) treatments applied in acute/sub-acute low back pain (LBP). The secondary purpose was to analyse the methodological properties of the included studies, and to identify theory-based treatment strategies that are applicable for physiotherapists. Method: A systematic literature search was conducted using four databases. Risk of bias of included studies was assessed and the methodological properties summarized. In addition, content and treatment theory of detected CBT-based strategies were systematically analysed and classified into three distinctive concepts of CBT: operant, cognitive and respondent treatment. Finally, applicability of treatment strategies in physiotherapy practice was discussed. Results: Eight studies were included in the present systematic review. Half of the studies suffered from high risk of bias, and study characteristics varied in all domains of methodology, particularly in terms of treatment design and outcome measures. Graded activity, an operant treatment approach based on principles of operant conditioning, was identified as a CBT-based strategy with traceable theoretical justification that can be applied by physiotherapists. Conclusion: Operant conditioning can be integrated in ambulant physiotherapy practice and is a promising CBT-based strategy for the prevention of chronic LBP. Implications for Rehabilitation Physiotherapist can integrate operant treatment approaches into their standard pain management for acute/sub-acute LBP. Graded activity, based on operant conditioning, is a promising treatment approach for the prevention of chronic LBP. Health care providers, other than only clinical psychologists, should deliver CBT- based treatment strategies, which aim to decrease pain behaviour by reinforcing exercise behaviour and active coping strategies.


World Psychiatry | 2017

Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis

Davy Vancampfort; Joseph Firth; Felipe B. Schuch; Simon Rosenbaum; James Mugisha; Mats Hallgren; Michel Probst; Philip B. Ward; Fiona Gaughran; Marc De Hert; André F. Carvalho; Brendon Stubbs

People with severe mental illness (schizophrenia, bipolar disorder or major depressive disorder) die up to 15 years prematurely due to chronic somatic comorbidities. Sedentary behavior and low physical activity are independent yet modifiable risk factors for cardiovascular disease and premature mortality in these people. A comprehensive meta‐analysis exploring these risk factors is lacking in this vulnerable population. We conducted a meta‐analysis investigating sedentary behavior and physical activity levels and their correlates in people with severe mental illness. Major electronic databases were searched from inception up to April 2017 for articles measuring sedentary behavior and/or physical activity with a self‐report questionnaire or an objective measure (e.g., accelerometer). Random effects meta‐analyses and meta‐regression analyses were conducted. Sixty‐nine studies were included (N=35,682; 39.5% male; mean age 43.0 years). People with severe mental illness spent on average 476.0 min per day (95% CI: 407.3‐545.4) being sedentary during waking hours, and were significantly more sedentary than age‐ and gender‐matched healthy controls (p=0.003). Their mean amount of moderate or vigorous physical activity was 38.4 min per day (95% CI: 32.0‐44.8), being significantly lower than that of healthy controls (p=0.002 for moderate activity, p<0.001 for vigorous activity). People with severe mental illness were significantly less likely than matched healthy controls to meet physical activity guidelines (odds ratio = 1.5; 95% CI: 1.1‐2.0, p<0.001, I2=95.8). Lower physical activity levels and non‐compliance with physical activity guidelines were associated with male gender, being single, unemployment, fewer years of education, higher body mass index, longer illness duration, antidepressant and antipsychotic medication use, lower cardiorespiratory fitness and a diagnosis of schizophrenia. People with bipolar disorder were the most physically active, yet spent most time being sedentary. Geographical differences were detected, and inpatients were more active than outpatients and those living in the community. Given the established health benefits of physical activity and its low levels in people with severe mental illness, future interventions specifically targeting the prevention of physical inactivity and sedentary behavior are warranted in this population.


Acta Psychiatrica Scandinavica | 2015

Promotion of cardiorespiratory fitness in schizophrenia: a clinical overview and meta- analysis

Davy Vancampfort; Simon Rosenbaum; Michel Probst; Andrew Soundy; Alex J. Mitchell; M. De Hert; Brendon Stubbs

Cardiorespiratory fitness (CRF) is a major modifiable risk factor for cardiovascular disease (CVD). We conducted a clinical overview to highlight the reduced CRF expressed as maximal oxygen uptake (VO2max) (or predicted) or peak oxygen uptake (VO2peak) in people with schizophrenia compared to the general population. We also aimed to identify correlates of and clinical strategies to improve CRF.

Collaboration


Dive into the Michel Probst's collaboration.

Top Co-Authors

Avatar

Davy Vancampfort

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Brendon Stubbs

South London and Maudsley NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Marc De Hert

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Andrew Soundy

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Simon Rosenbaum

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Johan Vanderlinden

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Guido Pieters

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Pascal Sienaert

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Amber De Herdt

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge